Cargando…
Platinum-doublet chemotherapy for advanced gastroenteropancreatic neuroendocrine carcinoma: a systematic review and meta-analysis
BACKGROUND: Platinum-doublet chemotherapy has been conventionally used for patients with advanced gastroenteropancreatic (GEP) neuroendocrine carcinoma (NEC) but evidence of chemotherapy is based on studies with small sample sizes and remains scarce. Thus, we conducted a systematic review and meta-a...
Autores principales: | Ohmoto, Akihiro, Fujiwara, Yu, Horita, Nobuyuki, Nakano, Kenji, Takahashi, Shunji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151982/ https://www.ncbi.nlm.nih.gov/pubmed/35635617 http://dx.doi.org/10.1007/s12672-022-00499-w |
Ejemplares similares
-
Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma
por: Ohmoto, Akihiro, et al.
Publicado: (2018) -
Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma
por: Ohmoto, Akihiro, et al.
Publicado: (2019) -
Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma
por: Ando, Takayuki, et al.
Publicado: (2015) -
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
por: Bongiovanni, Alberto, et al.
Publicado: (2015) -
Advances in the treatment of gastroenteropancreatic neuroendocrine tumors
por: Kunz, Pamela L, et al.
Publicado: (2010)